Viridian Therapeutics Inc. (VRDN)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 1 |
Ownership rank: | 706 |
% of all portfolios: | 0.011% |
| |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
1 |
$9,999,990 |
Sells |
0 |
$0 |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
24 Jan 2024 |
FAIRMOUNT FUNDS MANAGEMENT LLC |
Director , 10% |
22 Jan 2024 |
476,190 |
21.00 |
9,999,990 |
12 Apr 2023 |
MYERS SCOTT DUNSETH |
Chief Executive Officer |
12 Apr 2023 |
4,000 |
25.37 |
101,479 |
13 Mar 2023 |
MYERS SCOTT DUNSETH |
Chief Executive Officer |
13 Mar 2023 |
5,500 |
29.15 |
160,324 |
19 Aug 2022 |
FAIRMOUNT FUNDS MANAGEMENT LLC |
Director , 10% |
17 Aug 2022 |
425,531 |
23.50 |
9,999,978 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock